U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07092527) titled 'Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version' on July 21.
Brief Summary: This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Transgenderism
Reproductive Issues
Intervention:
DRUG: Testosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution
Participants in the initiating group will receive weekly doses of testosterone for gender-affirming care.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Califo...